Amyloidosis: all 495 studies
Page 3 of 5. Open to participants first (135), then studies with results posted, then the rest; newest registration first within each.
- Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain AmyloidosisCompletedNCT01318902Phase 1Results posted
- Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult SubjectsCompletedNCT01265394Phase 3Results posted
- Bendamustine and Dexamethasone in Patients With Relapsed AL AmyloidosisCompletedNCT01222260Phase 2Results posted
- Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem LevelsCompletedNCT01165554Phase 3Results posted
- Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) AmyloidosisCompletedNCT01083316Phase 2Results posted
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain AmyloidosisCompletedNCT01078454Phase 3Results posted
- Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain AmyloidosisCompletedNCT01072773Phase 2Results posted
- Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.CompletedNCT00928304Phase 2Results posted
- Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin AmyloidosisCompletedNCT00925002Phase 3Results posted
- A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL AmyloidosisCompletedNCT00890552Not applicableResults posted
- Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease PatientsCompletedNCT00857532Phase 2Results posted
- Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the BrainCompletedNCT00857415Phase 3Results posted
- An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid PolyneuropathyCompletedNCT00791492Phase 2/3Results posted
- Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00790647Phase 2Results posted
- Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersCompletedNCT00750282Phase 2Results posted
- Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal FluidCompletedNCT00742417Phase 2Results posted
- Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00679367Phase 2Results posted
- Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom BurdenCompletedNCT00651937Phase 2Results posted
- The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin AmyloidosisCompletedNCT00630864Phase 2Results posted
- Transthyretin Amyloidosis Outcome Survey (THAOS)CompletedNCT00628745Results posted
- Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00564889Phase 2Results posted
- CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or AmyloidosisCompletedNCT00558896Phase 2Results posted
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart DysfunctionCompletedNCT00547365Phase 1/2Results posted
- High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
- Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition DiseaseCompletedNCT00520767Phase 2Results posted
- Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00477971Phase 3Results posted
- Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic AmyloidosisCompletedNCT00458822Phase 2Results posted
- Safety and Efficacy Study of Fx-1006A in Patients With Familial AmyloidosisCompletedNCT00409175Phase 2/3Results posted
- Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-AmyloidosisCompletedNCT00298766Phase 1/2Results posted
- The Effect of Diflunisal on Familial AmyloidosisCompletedNCT00294671Phase 2/3Results posted
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
- CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00091260Phase 2Results posted
- 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) AmyloidosisTerminatedNCT00075608Phase 2Results posted
- S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic AmyloidosisCompletedNCT00064337Phase 2Results posted
- Fractional CO₂ Laser for Primary Cutaneous AmyloidosisCompletedNCT07815132Not applicable
- Study of Re-Treatment With ALXN2220 in Patients With ATTR-CMActive, not recruitingNCT07213583Phase 2
- BE.Amycon Registry UZ LeuvenWithdrawnNCT06998355
- REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosisCompletedNCT06788535Phase 3
- Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)Active, not recruitingNCT06629818Phase 2
- AL Amyloidosis and Anti-CD38-DaratunumabCompletedNCT06571864Not applicable
- A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese VolunteersCompletedNCT06527755Phase 1
- Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in RussiaCompletedNCT06414746
- Treatment of AA AmyloidosisCompletedNCT06397001Phase 1
- hATTR Polyneuropathy in RussiaCompletedNCT06365593
- Study of ALXN2220 Versus Placebo in Adults With ATTR-CMActive, not recruitingNCT06183931Phase 3
- Study of NXC-201 CAR-T in Patients With Light Chain (AL) AmyloidosisActive, not recruitingNCT06097832Phase 1/2
- The CARDIO-TTRansform Scintigraphy Sub-studyCompletedNCT06073587
- CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-studyCompletedNCT06073574
- Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)Active, not recruitingNCT05996406Phase 2
- Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection FractionActive, not recruitingNCT05896904Not applicable
- Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplantWithdrawnNCT05820763Phase 2
- Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid CardiomyopathyCompletedNCT05795400Not applicable
- Carpal Tunnel Release With Risk Factors for AmyloidosisCompletedNCT05793320Not applicable
- Identification of Clinically Significant Markers of ATTRv in Pre-symptomatic Mutation Carriers.Status unknownNCT05754099
- The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based MetabolomicsStatus unknownNCT05718401
- Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.Status unknownNCT05701410Not applicable
- Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis.Status unknownNCT05701397Not applicable
- Screening Algorithm for Early Detection of Occult Cardiac AmyloidosisCompletedNCT05693376
- An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL AmyloidosisWithdrawnNCT05692908Phase 1
- Antibiotics Against Amyloid AngiopathyStatus unknownNCT05680389Phase 1/2
- The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac AmyloidosisCompletedNCT05633563Phase 4
- Molecular Imaging of Myocardial Fibrosis in Cardiac AmyloidosisActive, not recruitingNCT05619302Phase 3
- Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With CardiomyopathyNo longer availableNCT05505838
- Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)WithdrawnNCT05486481Phase 1/2
- Comparison of OCTA Factors in Patients With or Without Amyloid Pathology: A Prospective StudyCompletedNCT05475158
- Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain AmyloidosisActive, not recruitingNCT05452850
- Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following ChemotherapyActive, not recruitingNCT05448716
- Cardiac Amyloidosis Prevalence and Outcome in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve ImplantationCompletedNCT05384418Not applicable
- Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment PatientsCompletedNCT05383053
- A PILOT Study on LSGB vs EMB in the Diagnosis of Cardiac Transthyretin AmyloidosisStatus unknownNCT05375279
- A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and VasculitisStatus unknownNCT05263817Early Phase 1
- MargheRITA (Remote Intelligence for Therapeutic Adherence)CompletedNCT05260203Not applicable
- carDIo-ttranSSfOrm nucLEar Imaging StudyTerminatedNCT05259072
- A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisActive, not recruitingNCT05250973Phase 2
- Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)Status unknownNCT05207475Not applicable
- A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic AmyloidosisCompletedNCT05201911Phase 1
- Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) AmyloidosisCompletedNCT05199337Phase 1/2
- Analysis of the Instestinal Microbiome of Patients With Transthyretin AmyloidosisStatus unknownNCT05196594
- Registry of Patients with Suspected Amyloidosis in Heart FailureActive, not recruitingNCT05176548
- Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart FailureStatus unknownNCT05167799
- Balance Eyesight and Muscle Tension in the Cervical Spine in Cerebral Amyloid AngiopathyCompletedNCT05082194
- Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis PatientsCompletedNCT05075798
- Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)CompletedNCT05064839Phase 3
- Association of β-amyloid 40 and 42 With PrediabetesCompletedNCT05035966
- Early Detection of Cardiac AmyloidosisStatus unknownNCT05010980
- Exercise Effect on Transthyretin StabilityStatus unknownNCT04986826
- Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory DiseaseWithdrawnNCT04984330Early Phase 1
- Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and PathologyStatus unknownNCT04983433
- The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy PatientsStatus unknownNCT04963985Phase 4
- High Resolution Three-dimensional Maps of the Right Chambers in Patient Diagnosed With Cardiac AmyloidosisStatus unknownNCT04956965Not applicable
- Isatuximab and Bendamustine in Systemic Light Chain AmyloidosisWithdrawnNCT04943302Phase 2
- A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in EuropeCompletedNCT04937777
- CLearing Alzheimer's Disease Molecular Pathology Without MedicationsStatus unknownNCT04913454Not applicable
- Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic StenosisCompletedNCT04899180Early Phase 1
- Daratumumab and Pomalidomide in Previously Treated Patients With AL AmyloidosisTerminatedNCT04895917Phase 2
- Substudy (NCT04456582): Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Two-dimensional Shear Wave Elastography) in Patients With Amyloidosis and Fabry Disease.Status unknownNCT04893889Not applicable
- Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)WithdrawnNCT04882735Phase 3
- Screening for Amyloidosis Before Aortic Valve Elective ReplacementActive, not recruitingNCT04869631
- A Non-interventional Cohort Safety Study of Patients With hATTR-PNActive, not recruitingNCT04850105
- ION-682884 in Patients With TTR Amyloid CardiomyopathyWithdrawnNCT04843020Phase 2